摘要
单链内生的~22nt的微小RNA的最新报道展示了它们不同的生物功能,包括细胞分化、细胞周期和病理学条件。最近的研究显示了微小RNA在干细胞工程中的潜在应用。微小RNA作为基因表达的后转录调节器发挥着重要作用,控制着骨母细胞调控的骨形成和破骨细胞相关的骨重塑。转录和转录后机制调节骨母细胞的分化和骨生成。骨母细胞的分化为骨骼肌的发展的关键步骤,且参与触发信号通路。信号通路如TGFβ、 BMP 和 Wnt是由微小RNA反调控的,因而与骨动力学和骨骼疾病有关。这篇综述突出微小RNA在骨母细胞分化的作用,并强调它们在骨代谢紊乱中的潜在治疗作用。
关键词: 骨紊乱,微小RNA,骨细胞分化,信号通路
Current Medicinal Chemistry
Title:Role of microRNAs in Osteoblasts Differentiation and Bone Disorders
Volume: 22 Issue: 6
Author(s): Yasir Arfat, Wei-Zhong Xiao, Munazza Ahmad, Fan Zhao, Di-Jie Li, Yu-Long Sun, Lifang Hu, Chen Zhihao, Ge Zhang, Salman Iftikhar, Peng Shang, Tuan-Ming Yang and Ai-Rong Qian
Affiliation:
关键词: 骨紊乱,微小RNA,骨细胞分化,信号通路
摘要: Advanced studies of single stranded endogenous ~22 nt microRNAs (miRNAs) have demonstrated their diverse biological functions including control of cell differentiation, cell cycle and pathological conditions. Recent studies suggest the potential application of miRNAs in stem cell engineering. miRNAs play a vital role as post-transcriptional regulators of gene expression which controls osteoblasts-mediated bone formation and osteoclasts related bone remodeling. Transcriptional and post-transcriptional mechanisms regulate the differentiation of osteoblasts and osteogenesis. The differentiation of osteoblasts is a key step in the development of skeletal muscles and it is involved in triggering the signaling pathways. Signaling pathways like TGFβ, BMP and Wnt are regulated by miRNAs which in turn, are shown to be associated with bone dynamics and bone disorders. This recap highlights the role of miRNAs in osteoblasts differentiation and emphasizes their potential therapeutic role in metabolic bone disorders.
Export Options
About this article
Cite this article as:
Yasir Arfat , Wei-Zhong Xiao , Munazza Ahmad , Fan Zhao , Di-Jie Li , Yu-Long Sun , Lifang Hu , Chen Zhihao , Ge Zhang , Salman Iftikhar , Peng Shang , Tuan-Ming Yang and Ai-Rong Qian , Role of microRNAs in Osteoblasts Differentiation and Bone Disorders, Current Medicinal Chemistry 2015; 22 (6) . https://dx.doi.org/10.2174/0929867321999141106121227
DOI https://dx.doi.org/10.2174/0929867321999141106121227 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A Rationale for the Use of Proton Pump Inhibitors as Antineoplastic Agents
Current Pharmaceutical Design The Role of Mitochondria in Cancer Induction, Progression and Changes in Metabolism
Mini-Reviews in Medicinal Chemistry Beta-Caryophyllene Suppresses Ovarian Cancer Proliferation by Inducing Cell Cycle Arrest and Apoptosis
Anti-Cancer Agents in Medicinal Chemistry Curcumin Targets in Inflammation and Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment
Current Medicinal Chemistry Tumor Stroma Manipulation By MSC
Current Drug Targets Radium-223: From Radiochemical Development to Clinical Applications in Targeted Cancer Therapy
Current Radiopharmaceuticals Targeting Telomerase by Antisense-Based Approaches: Perspectives for New Anti-Cancer Therapies
Current Pharmaceutical Design Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients
Current Pharmaceutical Design miRNAs in Melanoma: Tumor Suppressors and Oncogenes with Prognostic Potential
Current Medicinal Chemistry DTCM-glutarimide Delays Growth and Radiosensitizes Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Anti-Tumor Effects of 1,25-Dihydroxyvitamin D3 and Vitamin D Analogs
Current Pharmaceutical Design Mesenchymal Stem Cells Promote Caspase Expression in Molt-4 Leukemia Cells <i>Via</i> GSK-3α/Β and ERK1/2 Signaling Pathways as a Therapeutic Strategy
Current Gene Therapy Novel Agents Targeting Bioactive Sphingolipids for the Treatment of Cancer
Current Medicinal Chemistry Tanshinone IIA: Pharmacology, Total Synthesis, and Progress in Structure-modifications
Current Medicinal Chemistry Neuroprotective Effects of Non-Classical Estrogen-Like Signaling Activators: from Mechanism to Potential Implications
CNS & Neurological Disorders - Drug Targets TRAIL-Based Therapeutic Approaches for the Treatment of Pediatric Malignancies
Current Medicinal Chemistry Gallium in Cancer Treatment
Current Topics in Medicinal Chemistry Nanotechnology and Animal Health
Pharmaceutical Nanotechnology Utilising Nanotechnology and Nanosystems for Treatment of Rare Diseases
Pharmaceutical Nanotechnology